|

Dobutamine During Major Abdominal Surgery

RECRUITINGN/ASponsored by University of Hamburg-Eppendorf
Actively Recruiting
PhaseN/A
SponsorUniversity of Hamburg-Eppendorf
Started2025-06-16
Est. completion2026-03
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07000994

Summary

The PUSH-1 trial is a randomized, single-center pilot trial investigating whether dobutamine administration is feasible in patients having major abdominal surgery.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Consenting patients ≥18 years scheduled for elective major abdominal surgery under general anesthesia (expected surgery duration ≥ 120 minutes)
* Planned continuous intraarterial blood pressure monitoring using an arterial catheter for clinical indications not related to the trial

Exclusion Criteria:

* Emergency surgery
* Liver or kidney transplantation surgery
* Status of post transplantation of kidney, liver, heart, or lung
* Pregnancy
* Heart rhythms other than sinus rhythm

Conditions2

DepressionIntraoperative Myocardial Depression

Browse More Trials

Depression trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.